News & events

Constructive Bio's Founder and Chief Scientific Officer, Professor Jason Chin, has won the 2026 Heinrich Wieland Prize: one of Europe's most prestigious honours for fundamental research in the life sciences.

At #BIO2026, the whole industry is Driven by Purpose. Non-canonical amino acids let you engineer purpose-built design, purpose-built function, and purpose-built pharmacology into a molecule, at the level of a single amino acid.

Daniel de la Torre and Andre Pulschen are heading to Denver next week for hashtag#SEED2026.

Constructive Bio is joining the Department for Business and Trade (DBT) at London Tech Week 2026, 8–10 June at Olympia London. We're part of DBT's group of UK tech companies at the event.

What is the interplay of genetic code expansion, manufacturing and future of peptides? Our backers LongeVC have a great substack (well written Vlad Cernouţan!).

May Science Spotlight from the Constructive Bio team: Atanas Georgiev takes a look at a recent Nature Communications paper from Liu and colleagues exploring enzymatic synthesis of β-branched D-amino acids.

We’re delighted to welcome Boston-based biopharma leader Jim Weissman to Constructive Bio Board of Directors.